Skip to Content

Survival From COVID-19 High in Patients With Psoriasis

FRIDAY, Oct. 23, 2020 -- For patients with psoriasis, survival from COVID-19 is high, with increased hospitalization risk in association with nonbiologic systemic therapy versus biologic use, according to a study published online Oct. 16 in the Journal of Allergy and Clinical Immunology.

Satveer K. Mahil, M.D., Ph.D., from Guy's and St. Thomas' NHS Foundation Trust in London, and colleagues characterized the course of COVID-19 in psoriasis and identified factors associated with hospitalization using data from an international registry.

The researchers found that 71, 18, and 10 percent of the 374 clinician-reported patients from 25 countries were receiving a biologic, a nonbiologic, and no systemic treatment for psoriasis, respectively. Overall, 93 percent of the patients fully recovered from COVID-19; 22 and 2 percent were hospitalized and died, respectively. The risk for hospitalization was increased in association with older age (multivariable-adjusted odds ratio [OR], 1.59 per 10 years), male sex (OR, 2.51), non-White ethnicity (OR, 3.15), and comorbid chronic lung disease (OR, 3.87). Patients using nonbiologic systemic therapy were hospitalized more frequently than those on biologics (odds ratio, 2.84). There were no significant differences noted between biologic classes. Lower levels of social isolation were suggested in individuals receiving nonbiologic systemic therapy compared with biologics (OR, 0.68) using independent patient-reported data (1,626 patients across 48 countries).

"We can reassure our patients that the survival for people with psoriasis is high, and the risk factors for psoriasis patients are similar to those of the general population," Mahil said in a statement.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

© 2021 HealthDay. All rights reserved.

Posted: October 2020

Read this next

Physician's Briefing Weekly Coronavirus Roundup

Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 19 to 22, 2021. This roundup...

Adults Delaying Even Emergency Care During COVID-19

FRIDAY, Jan. 22, 2021 -- Two-thirds of Americans are concerned about going to medical appointments even for an emergency when COVID-19 rates are high in their area, according to...

Antibody Drug May Protect Nursing Home Residents, Staff From COVID-19

FRIDAY, Jan. 22, 2021 -- An antibody drug that has emergency use authorization from the U.S. Food and Drug Administration for use in early-stage COVID-19 patients with symptoms...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of in your inbox.